Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

Sensyne Health to help Bayer develop AI-enabled imaging solutions

Sensyne Health announced Thursday, Oct. 10, that it has joined Bayer’s newest innovation hub, LifeHub UK, and will work toward developing solutions for automated image evaluation.

Thumbnail

Cancer history, costs inhibit follow-up compliance among BI-RADS 3 patients

There is no shortage of research investigating the effectiveness of the Breast Imaging Reporting and Data System (BI-RADS) category 3 in mammography, but what’s less understood is why some women complete follow-up recommendations while many do not.

Thumbnail

AI improves image quality for diagnosis of liver lesions

AI can improve CT findings and play a key role in the evaluation of hypovascular hepatic metastases, according to a new study published in Radiology: Artificial Intelligence.

Change Healthcare introduces AI to its CDS system

Change Healthcare has added AI capabilities to its CareSelect Imaging clinical decision support (CDS) solution.

Thumbnail

What radiologists should know about vaping-related lung injuries

A group of U.S. researchers analyzed literature on the topic, summarizing imaging findings to help radiologists identify signs of vaping-related lung injuries. The results were published Oct. 8 in the American Journal of Roentgenology.

Thumbnail

Can AI match the performance of PI-RADS assessments?

A convolutional neural network (CNN) could assist radiologists with the detection and segmentation of suspicious findings on prostate MRI scans, according to a new study published in Radiology.

Thumbnail

New MRI technique uses lower magnetic field

National Institutes of Health experts have developed a new high-performing MRI method that uses a low magnetic field and could open a whole new wealth of possibilities for the technology.

SHINE closes $50M in financing to support isotope production

The funds, managed by Oaktree Capital Management, will support SHINE’s commercialization of molybdenum-99 and lutetium-177 (Lu-177) in addition to construction of the physical production facility.